SEC 13F Intelligence

Dana Investment Advisors, Inc. / ABBV

Dana Investment Advisors, Inc.’s Abbvie Inc Position

Does Dana Investment Advisors, Inc. own Abbvie Inc (ABBV)? Yes154.1K shares worth $34M (+1.00% of its 13F portfolio) as of Q1 2026, up from 147.5K shares the prior filed quarter.

Position Value
$34M
Q1 2026
Shares
154.1K
% of Portfolio
+1.00%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $1MQ2 ’19: $259,000Q3 ’19: $594,000Q4 ’19: $757,000Q4 ’19Q1 ’20: $655,000Q2 ’20: $20MQ3 ’20: $20MQ4 ’20: $24MQ4 ’20Q1 ’21: $27MQ2 ’21: $29MQ3 ’21: $30MQ4 ’21: $35MQ4 ’21Q1 ’22: $30MQ2 ’22: $36MQ3 ’22: $29MQ4 ’22: $35MQ4 ’22Q1 ’23: $31MQ2 ’23: $25MQ3 ’23: $27MQ4 ’23: $24MQ4 ’23Q1 ’24: $25MQ2 ’24: $26MQ3 ’24: $29MQ4 ’24: $27MQ4 ’24Q1 ’25: $32MQ2 ’25: $27MQ3 ’25: $35MQ4 ’25: $34MQ4 ’25Q1 ’26: $34Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026154.1K$34M+1.00%
Q4 2025147.5K$34M+0.98%
Q3 2025150.6K$35M+1.02%
Q2 2025146.6K$27M+0.90%
Q1 2025153.1K$32M+1.15%
Q4 2024154.7K$27M+0.91%
Q3 2024147.1K$29M+0.96%
Q2 2024150.1K$26M+0.87%
Q1 2024139.8K$25M+0.85%
Q4 2023154.1K$24M+1.15%
Q3 2023179.7K$27M+1.37%
Q2 2023185.9K$25M+1.23%
Q1 2023194.2K$31M+1.57%
Q4 2022213.8K$35M+1.81%
Q3 2022216.4K$29M+1.65%
Q2 2022233.4K$36M+1.81%
Q1 2022183.9K$30M+1.38%
Q4 2021255.4K$35M+1.50%
Q3 2021275.3K$30M+1.34%
Q2 2021254.3K$29M+1.27%
Q1 2021250.3K$27M+1.25%
Q4 2020226.6K$24M+1.21%
Q3 2020231.7K$20M+1.10%
Q2 2020199.1K$20M+1.06%
Q1 20208.6K$655,000+0.04%
Q4 20198.6K$757,000+0.04%
Q3 20197.8K$594,000+0.03%
Q2 20193.6K$259,000+0.01%
Q1 201917.7K$1M+0.07%
Q4 201818.1K$2M+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dana Investment Advisors, Inc.’s full portfolio or all institutional holders of ABBV.